Journal of Cellular and Molecular Medicine 2024

10 papers
In 2024, the Journal of Cellular and Molecular Medicine featured research centered on oncology, bioinformatics, and molecular pathology. A significant portion of the work focused on identifying prognostic biomarkers and therapeutic targets in various malignancies, including clear cell renal cell carcinoma, gastric cancer, and acute myeloid leukaemia. Researchers utilized methodologies such as single-cell RNA sequencing and weighted gene co-expression network analysis to explore tumor-associated genes and molecular pathways like the AKT/FBLN2 axis. Another prominent trend was the application of computational models and deep learning for biological predictions. This included the development of multi-Laplacian regularized models for piRNA-disease associations and heterogeneous network learning for drug-target interaction prediction. Additionally, studies investigated molecular mechanisms in non-oncological contexts, such as the role of the miR-874-3p/ATF3 axis in intervertebral disc degeneration and the antifungal effects of fangchinoline. Notable contributors to this year's volume included authors such as Bichao Lu, Junsong Wu, Liping Yang, and Xuefeng Liu.

Top Research Directions

The 34 research directions with Journal of Cellular and Molecular Medicine 2024 papers, ranked by paper count, next to 2023. Share is the fraction of the edition’s papers in the direction.

#Direction20242023Share 2024Share 20232023 rank
1Resolving Cellular Heterogeneity via Single Cell Transcriptomics2020.0%0.0%—
2Biophysical Mechanisms of Biofilm Mediated Antimicrobial Resistance1010.0%0.0%—
3Computational Frameworks for Drug Repurposing1110.0%11.1%9
4Computational Prioritization to Overcome Experimental Validation Bottlenecks1010.0%0.0%—
5Detecting Molecular Signatures via Differential Gene Expression Analysis1010.0%0.0%—
6Dual Luciferase Reporter Assays for MicroRNA Target Validation1010.0%0.0%—
7Elucidating the Molecular Mechanisms of Phenotypic Hits1010.0%0.0%—
8Experimental Validation of Non-Coding RNA Targets1010.0%0.0%—
9Heterogeneous Network Fusion for Biomedical Discovery1010.0%0.0%—
10Hybrid Explicit and Implicit Feature Interaction Modeling1010.0%0.0%—
11Identifying Functional Gene Modules via Co-Expression Networks1010.0%0.0%—
12Interpreting Gene Expression via Functional Enrichment Analysis1010.0%0.0%—
13LASSO Cox Regression for High Dimensional Survival Modeling1010.0%0.0%—
14Mechanisms of Anoikis Resistance in Cancer Metastasis1010.0%0.0%—
15MicroRNA Mediated Post Transcriptional Gene Silencing1010.0%0.0%—
16MicroRNA Signatures as Independent Prognostic Biomarkers in Cancer1010.0%0.0%—
17Molecular Cascades Driving Cancer Metastasis1110.0%11.1%16
18Multicellular Ecosystems and Ecotypes in the Tumor Microenvironment1110.0%11.1%19
19Optical Probes for Quantifying Intracellular Reactive Oxygen Species1010.0%0.0%—
20Overcoming Data Scarcity in Rare Disease Research1010.0%0.0%—
21Overcoming Data Sparsity in Single Cell Sequencing1010.0%0.0%—
22Principles of Protein Expression Analysis via Western Blotting1110.0%11.1%22
23Prognostic Value Assessment via Cancer Survival Analysis1110.0%11.1%23
24Proteomic Biomarkers for Cancer Prognosis and Treatment Response1010.0%0.0%—
25Pseudotime Trajectory Inference from Single-Cell Snapshots1010.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Cellular and Molecular Medicine 2024 papers: a paper credits every institution named in its affiliations, once. 21 institutions share 8 credited papers.

#InstitutionPapersShare20232023 rank
100g5b0g93 112.5%13
2021f4v087 112.5%0—
302jecxg34 112.5%0—
4030e3n504 112.5%0—
503vt3fq09 112.5%0—
604cgmg165 112.5%0—
704gjmb875 112.5%0—
8051jg5p78 112.5%0—
9Capital Medical University 112.5%0—
10Chinese Academy of Sciences 112.5%0—
11Guangxi University 112.5%0—
12Hangzhou City University 112.5%0—
13Hubei University of Chinese Medicine 112.5%0—
14Jilin University 112.5%15
15Shenzhen Institutes of Advanced Technology 112.5%0—
16Soochow University 112.5%0—
17Tianjin Hospital 112.5%0—
18Tianjin University 112.5%0—
19University of Saskatchewan 112.5%0—
20Xi'an University of Technology 112.5%0—
21Zhejiang Normal University 112.5%0—

Download all institutions as CSV

About this data

Papers. Journal of Cellular and Molecular Medicine 2024 lists 10 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2023 use shares, since the edition went from 9 to 10 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 8 of 10 papers (80.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Cellular and Molecular Medicine 2024”, https://lacuna.tiptreesystems.com/venue/journal-of-cellular-and-molecular-medicine/2024.

Top Authors

AuthorPapers
Qingfeng Chen1

Impactful Papers

Papers from Journal of Cellular and Molecular Medicine 2024 that shaped research clusters.

Influential

Papers

Title
A novel ARHGAP family gene signature for survival prediction in glioma patients
Exploring the Prognostic Value of Tumour‐Associated Genes in Clear Cell Renal Cell Carcinoma Through Single‐Cell <scp>RNA</scp> Sequencing Insights
Fangchinoline inhibits growth and biofilm of Candida albicans by inducing <scp>ROS</scp> overproduction
Identification of two key biomarkers <scp>CD93</scp> and <scp>FGL2</scp> associated with survival of acute myeloid leukaemia by weighted gene co‐expression network analysis
Identifying the protective effects of <scp>miR</scp>‐874‐3p/<scp>ATF3</scp> axis in intervertebral disc degeneration by single‐cell <scp>RNA</scp> sequencing and validation
MRDPDA: A multi‐Laplacian regularized deepFM model for predicting piRNA‐disease associations
Research progress on the roles of dopamine and dopamine receptors in digestive system diseases
<scp>ITGBL1</scp> promotes anoikis resistance and metastasis in human gastric cancer via the <scp>AKT</scp>/<scp>FBLN2</scp> axis
<scp>NGCN</scp>: <scp>Drug‐target</scp> interaction prediction by integrating information and feature learning from heterogeneous network
Unveiling the role of RAC3 in the growth and invasion of cisplatin‐resistant bladder cancer cells